Menu
  • Join
  • Login
  • Contact
 

Search abstracts


Novel dual controlled release cilostazol tablets as a patient-centric delivery system: in vitro and in vivo bioavailability in dogs and human volunteers

  • At: 2014 FIP Congress in Bangkok (Thailand)
  • Type: Poster
  • By: LEE, Beom-Jin (Ajou University, College of Pharmacy, Suwon, South-Korea)
  • Co-author(s): Cho, Sang-Min (Ajou University, Suwon, South-Korea)
    Choi, Yun-Woong (Korea United Pharm, Seoul, South-Korea)
    Park, Chulhun (Ajou University, Suwon, South-Korea)
    Kang, Taehee (Ajou University, Suwon, South-Korea)
  • Abstract:

    Cilostazol has been used as an antiplatelet vasodilator agent twice a day. However, it has some pharmaceutical limitations due to its low water solubility, large fluctuation of blood-concentration and unwanted side-effects such as headache, pyknocardia and heavy-headed symptoms. To overcome these pharmaceutical issues, novel dual controlled..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses